Altered calcium handling is an early sign of streptozotocin-induced diabetic cardiomyopathy

International Journal of Molecular Medicine

Volumn 17, Issue 6, 2006, Pages 1035-1043

  Ligeti, László ^a   Szenczi, Orsolya ^a   Prestia, Christina M ^a   Szabó, Csaba ^a   Horváth, Katalin ^b   Marcsek, Zoltán L ^b   Van Stiphout, Ruud G P M ^c   Van Riel, Natal A W ^c   Den Buijs, Jorn Op ^c   Van Der Vusse, Ger J ^d   Ivanics, Tamás ^a  

^a SEMMELWEIS UNIVERSITY   (Hungary)

^b Natl Institute of Chemical Safety   (Hungary)

^c EINDHOVEN UNIVERSITY OF TECHNOLOGY   (Netherlands)

^d MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

Cardiac function; Diabetes; Intracellular calcium handling; Poly(ADP ribose) polymerase; RyR2; SERCA2A

Indexed keywords

ADENOSINE TRIPHOSPHATASE (CALCIUM); CALCIUM; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; RYANODINE RECEPTOR; SARCOPLASMIC RETICULUM CALCIUM TRANSPORTING ADENOSINE TRIPHOSPHATASE;

ANIMAL; ARTICLE; CARDIOMYOPATHY; CHEMISTRY; DIABETIC ANGIOPATHY; DRUG ANTAGONISM; EXPERIMENTAL DIABETES MELLITUS; HEART CONTRACTION; HEART MUSCLE; HEMODYNAMICS; MALE; METABOLISM; PATHOPHYSIOLOGY; RAT; SARCOPLASMIC RETICULUM; SPRAGUE DAWLEY RAT;

ANIMALS; CALCIUM; CALCIUM-TRANSPORTING ATPASES; CARDIOMYOPATHIES; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC ANGIOPATHIES; HEMODYNAMIC PROCESSES; MALE; MYOCARDIAL CONTRACTION; MYOCARDIUM; POLY(ADP-RIBOSE) POLYMERASES; RATS; RATS, SPRAGUE-DAWLEY; RYANODINE RECEPTOR CALCIUM RELEASE CHANNEL; SARCOPLASMIC RETICULUM; SARCOPLASMIC RETICULUM CALCIUM-TRANSPORTING ATPASES;

EID: 33745685229     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.17.6.1035     Document Type: Article

References (36)

1. Fein FS, Kornstein LB, Strobeck JE, Capasso JM and Sonnenblick EH: Altered myocardial mechanics in diabetic rats. Circ Res 47: 922-933, 1980.
2. Galderisi M, Anderson KM, Wilson PW and Levy D: Echocardiographic evidence for the existence of a distinct diabetic cardiomyopathy (the Framingham Heart Study). Am J Cardiol 68: 85-89, 1991.
3. 2+ in the heart during diabetes. Cardiovasc Res 34: 41-47, 1997.
4. 2+ signaling contributes to cardiomyopathy in type 1 diabetic rats. Am J Physiol 283: H1398-H1408, 2002.
5. Pacher P, Liaudet L, Soriano FG, Mabley JG, Szabo E and Szabo C: The role of poly(ADP-ribose) polymerase activation in the development of myocardial and endothelial dysfunction in diabetes. Diabetes 51: 514-521, 2002. (Pubitemid 34764811)
6. Szabo C, Mabley JG, Moeller SM, et al: Part I: pathogenetic role of peroxynitrite in the development of diabetes and diabetic vascular complications: studies with FP15, a novel potent peroxynitrite decomposition catalyst. Mol Med 8: 571-580, 2002. (Pubitemid 36337502)
7. Jagtap P and Szabo C: Poly(ADP-ribose) polymerase and the therapeutic effects of its inhibitors. Nat Rev Drug Discov 4: 421-440, 2005.
8. Pacher P, Schulz R, Liaudet L and Szabo C: Nitrosative stress and pharmacological modulation of heart failure. Trends Pharmacol Sci 26: 302-310, 2005.
9. Depre C, Young ME, Ying J, et al: Streptozotocin-induced changes in cardiac gene expression in the absence of severe contractile dysfunction. J Mol Cell Cardiol 32: 985-996, 2000. (Pubitemid 30663106)
10. Mihm MJ, Seifert JL, Coyle CM and Bauer JA: Diabetes related cardiomyopathy time-dependent echocardiographic evaluation in an experimental rat model. Life Sci 69: 527-542, 2001.
11. Yu JZ, Rodrigues B and McNeill JH: Intracellular calcium levels are unchanged in the diabetic heart. Cardiovasc Res 34: 91-98, 1997.
12. Bidasee KR, Dincer UD and Besch HR Jr: Ryanodine receptor dysfunction in hearts of streptozotocin-induced diabetic rats. Mol Pharmacol 60: 1356-1364, 2001.
13. 2+ exchanger activity in the diabetic heart. Cardiovasc Res 34: 129-136, 1997.
14. Bidasee KR, Zhang Y, Shao CH, et al: Diabetes increases formation of advanced glycation end products on Sarco(endo)-plasmic reticulum Ca2+-ATPase. Diabetes 53: 463-473, 2004. (Pubitemid 38174564)
15. Op den Buijs J, Miklos Z, van Riel NA, et al: Beta-adrenergic activation reveals impaired cardiac calcium handling at early stage of diabetes. Life Sci 76: 1083-1098, 2005. (Pubitemid 40037531)
16. Szenczi O, Kemecsei P, Holthuijsen MFJ, et al: Poly(ADP-ribose) polymerase regulates myocardial calcium handling in doxorubicin-induced heart failure. Biochem Pharmacol 69: 725-732, 2005. (Pubitemid 40248615)
17. Pacher P, Liaudet L, Mabley J, Komjati K and Szabo C: Pharmacologic inhibition of poly(adenosine diphosphate-ribose) polymerase may represent a novel therapeutic approach in chronic heart failure. J Am Coll Cardiol 40: 1006-1016, 2002.
18. 2+ indicators with greatly improved fluorescence properties. J Biol Chem 260: 3440-3450, 1985.
19. i in intact rabbit cardiac myocytes. Biophys J 68: 1453-1460, 1995.
20. Bers DM: Calcium fluxes involved in control of cardiac myocyte contraction. Circ Res 87: 275-281, 2000.
21. 2+ oscillations. Biophys J 67: 447-456, 1994.
22. Bradford MM: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248-254, 1976.
23. Malhotra A, Reich D, Reich D, et al: Experimental diabetes is associated with functional activation of protein kinase C epsilon and phosphorylation of troponin I in the heart, which are prevented by angiotensin II receptor blockade. Circ Res 81: 1027-1033, 1997.
24. Ozdemir S, Ungur M, Gurdal H and Turan B: Treatment with AT(1) receptor blocker restores diabetes-induced alterations in intracellular Ca(2+) transients and contractile function of rat myocardium. Arch Biochem Biophys 435: 166-174, 2005.
25. Mozaffari MS, Wilson GL and Schaffer SW: Effect of chronic sulfonylurea treatment on the myocardium of insulin-dependent diabetic rats. Can J Physiol Pharmacol 66: 1481-1486, 1988. (Pubitemid 19046757)
26. Zhong Y, Ahmed S, Grupp IL and Matlib MA: Altered SR protein expression associated with contractile dysfunction in diabetic rat hearts. Am J Physiol 281: H1137-H1147, 2001.
27. Balke CW, Egan TM and Wier WG: Processes that remove calcium from the cytoplasm during excitation-contraction coupling in intact rat heart cells. J Physiol 474: 447-462, 1994.
28. Allo SN, Lincoln TM, Wilson GL, Green FJ, Watanabe AM and Schaffer SW: Non-insulin-dependent diabetes-induced defects in cardiac cellular calcium regulation. Am J Physiol 260: C1165-C1171, 1991.
29. 2+ transport. Arch Biochem Biophys 387: 85-92, 2001.
30. Zhang GX, Kimura S, Nishiyama A, et al: Cardiac oxidative stress in acute and chronic isoproterenol-infused rats. Cardiovasc Res 65: 230-238, 2005. (Pubitemid 40038496)
31. Bigelow DJ and Squier TC: Redox modulation of cellular signaling and metabolism through reversible oxidation of methionine sensors in calcium regulatory proteins. Biochim Biophys Acta 1703: 121-134, 2005.
32. Trost SU, Belke DD, Bluhm WF, Meyer M, Swanson E and Dillmann WH: Overexpression of the sarcoplasmic reticulum Ca(2+)-ATPase improves myocardial contractility in diabetic cardiomyopathy. Diabetes 51: 1166-1171, 2002.
33. 2+ handling in normal and diabetic rat hearts. FASEB J 16: 1657-1659, 2002.
34. Zarain-Herzberg A, Yano K, Elimban V and Dhalla NS: Cardiac sarcoplasmic reticulum Ca(2+)-ATPase expression in streptozotocin-induced diabetic rat heart. Biochem Biophys Res Commun 203: 113-120, 1994. (Pubitemid 124009318)
35. + ATPase activities and gene expression in alloxaninduced diabetes in rats. Mol Cell Biochem 188: 91-101, 1998.
36. 2+ overload. J Physiol 527: 85-94, 2000.